Merck seeks USFDA nod for Keytruda to treat non-small cell lung cancer Ruchika Sharma14 Jun 2022 12:00 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
US FDA directs risk of suicide disclosure on Merck antibaldness pill Propecia Ruchika Sharma12 Jun 2022 10:55 AM ISTNew Delhi: The U.S. health regulators, the USFDA rejected a request to remove popular anti-baldness pill Propecia and its generic versions from the...
Biocytogen enters into antibody agreement with Merck Ruchika Sharma3 May 2022 9:00 AM ISTBeijing: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has announced that the company has entered into an evaluation and option agreement with Merck...
Merck KEYTRUDA gets European nod to treat Deficient Mismatch Repair tumors Ruchika Sharma2 May 2022 1:00 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck Pneumococcal vaccine gets USFDA Breakthrough Therapy Designation Ruchika Sharma16 April 2022 12:47 PM ISTThe Breakthrough Therapy Designation is an FDA program designed to expedite the development and review of products intended for serious or...
Merck gets positive EU CHMP opinion for Keytruda for patients with MSI-H or dMMR tumors in five different types of cancer Ruchika Sharma28 March 2022 10:30 AM ISTKeytruda is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Merck expects 2022 sales up nearly 20 percent, mostly on molnupiravir Ruchika Sharma6 Feb 2022 9:00 AM ISTNew Delhi: Merck & Co said on Thursday it expects its 2022 sales to increase as much as 18 percent over last year, mostly on sales of its new...
Merck COVID drug Molnupiravir last choice for US patients: Report Ruchika Sharma2 Feb 2022 12:07 PM ISTNew Delhi: Merck & Co's new antiviral pill, once touted as a potential game changer for treating COVID-19, is the last choice among four...
Fate of Pfizer COVID pill Paxlovid to be decided by EU regulator by January end: Report Ruchika Sharma26 Jan 2022 9:30 AM ISTBrussels: The European Union's drug regulator is set to decide whether to approve Pfizer's Covid-19 pill at the end of this month, before a final...
No USFDA approval for Merck cough drug Gefapixant Ruchika Sharma25 Jan 2022 12:47 PM ISTNew Delhi: Merck & Co said on Monday the U.S. Food and Drug Administration declined to approve its experimental drug for the treatment...
Merck COVID pill Molnupiravir likely to get WHO recommendation in February Ruchika Sharma15 Jan 2022 1:00 PM ISTNew Delhi: The World Health Organization (WHO) is currently reviewing Merck's COVID-19 antiviral oral pill molnupiravir and a recommendation will...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima Ruchika Sharma30 Dec 2021 12:22 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
